My Account

Risk Management
Workers Comp & Safety
Employee Benefits
International
People
Events
BI Intelligence
Magazine
- Current Issue
- Past Issues
DEI Institute

Recent Quotes

View Full List

My Watchlist

Indicators

Business Insurance Index

Markets:

Overview

News

Currencies

International

Treasuries

InspireMD Inc. - Common Stock (NQ:NSPR)

2.045 +0.175 (+9.36%)

Streaming Delayed Price Updated: 1:40 PM EST, Nov 14, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about InspireMD Inc. - Common Stock

< Previous 1 2 3 Next >

Why Are InspireMD Shares Surging Today ↗

May 15, 2023

Via Benzinga

InspireMD's Return On Capital Employed Insights ↗

March 31, 2023

Via Benzinga

Earnings Scheduled For March 30, 2023 ↗

March 30, 2023

Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is estimated to report quarterly loss at $0.12 per share on revenue of $10.80 million.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

October 26, 2022

On Wednesday, 53 companies reached new 52-week lows.

Via Benzinga

InspireMD: Q2 Earnings Insights ↗

August 09, 2022

InspireMD (NASDAQ:NSPR) reported its Q2 earnings results on Tuesday, August 9, 2022 at 06:30 AM. Here's what investors need to know about the announcement.

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

November 04, 2022

Friday's session saw 236 companies set new 52-week lows.

Via Benzinga

Recap: InspireMD Q1 Earnings ↗

May 10, 2022

InspireMD (NASDAQ:NSPR) reported its Q1 earnings results on Tuesday, May 10, 2022 at 06:30 AM. Here's what investors need to know about the announcement.

Via Benzinga

Recap: InspireMD Q4 Earnings ↗

March 08, 2022

InspireMD (NASDAQ:NSPR) reported its Q4 earnings results on Tuesday, March 8, 2022 at 06:30 AM. Here's what investors need to know about the announcement. Earnings...

Via Benzinga

NAMSA and InspireMD Announce Strategic Outsourcing Partnership to Accelerate New Product Development

September 08, 2022

From NAMSA

Via Business Wire

$7.3 Million Bet On This Penny Stock? Check Out These 4 Penny Stocks Insiders Are Buying ↗

August 23, 2022

The Dow Jones dropped more than 600 points on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern...

Via Benzinga

5 Stocks To Watch For June 6, 2022 ↗

June 06, 2022

Some of the stocks that may grab investor focus today are:

Via Benzinga

Looking Into InspireMD's Return On Capital Employed ↗

March 10, 2022

InspireMD (AMEX:NSPR) brought in sales totaling $1.38 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 0.64%, resulting in a loss of $4.10...

Via Benzinga

InspireMD: Q4 Earnings Insights ↗

March 08, 2022

InspireMD (NASDAQ:NSPR) reported its Q4 earnings results on Tuesday, March 8, 2022 at 06:30 AM. Here's what investors need to know about the announcement. Earnings...

Via Benzinga

Preview: InspireMD's Earnings ↗

March 07, 2022

InspireMD (AMEX:NSPR) is set to give its latest quarterly earnings report on Tuesday, 2022-03-08. Here's what investors need to know before the announcement. Analysts estimate...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

March 08, 2022

Gainers Stealth BioTherapeutics (NASDAQ:MITO) shares increased by 22.1% to $0.65 during Tuesday's pre-market session. The company's market cap stands at $37.4...

Via Benzinga

The Daily Biotech Pulse: Moderna Outlines Steps For mRNA Tech Advancement, Voyager-Novartis Strike Licensing Deal, Valneva Reports Positive Chikungunya Shot Readout ↗

March 08, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Moderna Announces 4 Initiatives To Advance mRNA Vaccines As Preventative...

Via Benzinga

Earnings Preview For InspireMD ↗

March 07, 2022

InspireMD (AMEX:NSPR) is set to give its latest quarterly earnings report on Tuesday, 2022-03-08. Here's what investors need to know before the announcement. Analysts estimate...

Via Benzinga

4 Penny Stocks Insiders Are Buying ↗

December 03, 2021

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders intereste...

Via Benzinga

Earnings Scheduled For March 8, 2022 ↗

March 08, 2022

Companies Reporting Before The Bell • Babcock & Wilcox (NYSE:BW) is likely to report quarterly earnings at $0.10 per share on revenue of $196.62 million. •...

Via Benzinga

The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg ↗

March 06, 2022

Biotech stocks reversed course in the week ending March 4, as the Ukrainian crisis weighed down on the broader market as well as the sector. The iShares Biotechnology ETF (...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

December 01, 2021

Gainers Hoth Therapeutics (NASDAQ:HOTH) s...

Via Benzinga

5 Penny Stocks Insiders Are Buying ↗

November 29, 2021

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders intereste...

Via Benzinga

5 Penny Stocks Insiders Are Buying ↗

November 24, 2021

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and ...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

November 23, 2021

Gainers Biolase (NASDAQ:BIOL) shares incr...

Via Benzinga

50 Biggest Movers From Yesterday ↗

October 14, 2021

Gainers Jasper Therapeutics, Inc. (NASDAQ: JSPR) shares surged 105.1% to close at $14.79 on Wednesday after Oppenheimer initiated coverage on the stock with an Outperform rating...

Via Benzinga

40 Stocks Moving In Wednesday's Mid-Day Session ↗

October 13, 2021

Gainers Jasper Therapeutics, Inc. (NASDAQ: JSPR) shares jumped 113% to $15.36 after Oppenheimer initiated coverage on the stock with an Outperform rating and a $21 price target...

Via Benzinga

Mid-Morning Market Update: Markets Mixed; JPMorgan Posts Upbeat Earnings ↗

October 13, 2021

Following the market opening Wednesday, the Dow traded down 0.36% to 34,254.62 while the NASDAQ rose 0.27% to 14,505.47. The S&P also fell, dropping 0.07% to 4,347.49. The U.S...

Via Benzinga

Topics Stocks

3 Penny Stocks Insiders Are Buying ↗

August 27, 2021

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider...

Via Benzinga

60 Biggest Movers From Friday ↗

August 30, 2021

Gainers Vinco Ventures, Inc. (NASDAQ: BBIG) shares rose 80.9% to close at $5.30 on Friday. The company recently reported a Q2 loss of $5.13 per share. Navios Maritime Acquisition...

Via Benzinga

InspireMD Reports Narrower Loss In Q2 As Revenue Rebounds On Procedural Recovery ↗

August 10, 2021

InspireMD Inc (NASDAQ: NSPR) has recorded a robust increase in second-quarter FY21 sales of $1.04 million, +231.6% Y/Y, slightly missing the consensus of $1.1...

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.

Information

About Us
Contact
Advertise
Privacy Policy
Terms & Condition